Etretinate

Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.

Cross Reference

Introduction

To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Etretinate?

Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

No disease MeSH terms mapped to the current reference collection.

PubChem Associated disorders and diseases

What pathways are associated with Etretinate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Etretinate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Etretinate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Etretinate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Etretinate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Etretinate

Download all related citations
Per page 10 20 50 100 | Total 1071
Authors Title Published Journal PubMed Link
Schmutz JL et al. [Treatment with acitretin and alcohol drinking: a high risk combination]. 2001 Ann Dermatol Venereol pmid:11908183
Kreiss C et al. Severe cholestatic hepatitis in a patient taking acitretin. 2002 Am. J. Gastroenterol. pmid:11922592
Fujii K et al. Short-term etretinate therapy for prurigo chronica multiformis. 2002 J. Dermatol. pmid:11990249
Schopf RE et al. A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis. 2002 J. Invest. Dermatol. pmid:12164939
Hu W et al. Acrokeratoelastoidosis. 2002 Jul-Aug Pediatr Dermatol pmid:12220276
Ogasawara Y et al. A case of multiple keratoacanthoma centrifugum marginatum: response to oral etretinate. 2003 J. Am. Acad. Dermatol. pmid:12582405
Liu Y et al. Sharing of the same embryogenic pathway in anorectal malformations and anterior sacral myelomeningocele formation. 2003 Pediatr. Surg. Int. pmid:12682745
Sahin MT et al. Acrodermatitis continua of Hallopeau: was it an outcome of a surgical trauma or initially misdiagnosed as onychomycosis? 2003 J Eur Acad Dermatol Venereol pmid:12705767
Corazza M et al. Primary cutaneous CD30+ large T-cell lymphoma in a patient with psoriasis treated with cyclosporine. 2003 Dermatology (Basel) pmid:12771475
Budzyńska B et al. The epidermis mitochondria ultrastructure evaluation of the etretinate-treated white rat. 2002 Ann Univ Mariae Curie Sklodowska Med pmid:12898836
Giam YC Etretinate treatment for Harlequin baby. 1992 J Singapore Paediatr Soc pmid:1305665
Rao GN et al. Na+/H+ antiporter gene expression increases during retinoic acid-induced granulocytic differentiation of HL60 cells. 1992 J. Cell. Physiol. pmid:1315322
Harnish DC et al. Mouse conceptuses have a limited capacity to elevate the mRNA level of cellular retinoid binding proteins in response to teratogenic doses of retinoic acid. 1992 Teratology pmid:1332208
Chien DS et al. Systemic pharmacokinetics of acitretin, etretinate, isotretinoin, and acetylenic retinoids in guinea pigs and obese rats. 1992 Mar-Apr Drug Metab. Dispos. pmid:1352212
West MR et al. Simple assays of retinoid activity as potential screens for compounds that may be useful in treatment of psoriasis. 1992 J. Invest. Dermatol. pmid:1376755
Humphreys F et al. Paraneoplastic follicular hyperkeratosis responsive to etretinate. 1992 Br. J. Dermatol. pmid:1379064
Szmurlo A et al. Antitumor action of retinoids: inhibition of tumor cell line-induced angiogenesis and prevention of tumors in mice. 1992 Dermatology (Basel) pmid:1379857
Power HT et al. Use of etretinate for treatment of primary keratinization disorders (idiopathic seborrhea) in cocker spaniels, west highland white terriers, and basset hounds. 1992 J. Am. Vet. Med. Assoc. pmid:1387126
Shiohara T et al. Differential effects of cyclosporine and etretinate on serum cytokine levels in patients with psoriasis. 1992 J. Am. Acad. Dermatol. pmid:1401309
Klein J et al. Therapeutic drug monitoring of retinoids. 1992 Ther Drug Monit pmid:1412605